| Feeling of vigour | In healthy adults aged 40 and over, neither ubiquinone nor ubiquinol showed a convincing advantage in the vigour rating over eight weeks.No significant advantage was reported. The main text gives p>0.44 for secondary outcomes, and the abstract p>0.16. | 2/4 LowPrecision of the estimate: The exact CI for each form versus placebo was not extracted. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: The study tested the specific form, participant group and outcome stated. Possible publication bias: There are no specific data for a separate downgrade. Study methods: Multiple secondary measures in five groups. | 11 trial; outcome in the same participant groupA Randomized, Double-Blind, Placebo-Controlled Trial Comparing the Effects of Commercially Available Ubiquinone, Ubiquinol, and Geranylgeraniol Dietary Supplements on Plasma CoQ10 Concentrations ↗ | 150 healthy adults aged 40 and over allocated to five groups | - A Randomized, Double-Blind, Placebo-Controlled Trial Comparing the Effects of Commercially Available Ubiquinone, Ubiquinol, and Geranylgeraniol Dietary Supplements on Plasma CoQ10 Concentrations ↗
|
|---|
| Vitality questionnaire score | Neither ubiquinone nor ubiquinol showed a convincing advantage in the vitality rating compared with placebo.No significant advantage was reported. The main text gives p>0.44 for secondary outcomes, and the abstract p>0.16. | 2/4 LowPrecision of the estimate: The exact CI for each form versus placebo was not extracted. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: The study tested the specific form, participant group and outcome stated. Possible publication bias: There are no specific data for a separate downgrade. Study methods: Multiple secondary measures in five groups. | 11 trial; outcome in the same participant groupA Randomized, Double-Blind, Placebo-Controlled Trial Comparing the Effects of Commercially Available Ubiquinone, Ubiquinol, and Geranylgeraniol Dietary Supplements on Plasma CoQ10 Concentrations ↗ | 150 healthy adults aged 40 and over allocated to five groups | - A Randomized, Double-Blind, Placebo-Controlled Trial Comparing the Effects of Commercially Available Ubiquinone, Ubiquinol, and Geranylgeraniol Dietary Supplements on Plasma CoQ10 Concentrations ↗
|
|---|
| General health questionnaire score | Neither ubiquinone nor ubiquinol showed a convincing advantage in the general health rating compared with placebo.No significant advantage was reported. The main text gives p>0.44 for secondary outcomes, and the abstract p>0.16. | 2/4 LowPrecision of the estimate: The exact CI for each form versus placebo was not extracted. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: The study tested the specific form, participant group and outcome stated. Possible publication bias: There are no specific data for a separate downgrade. Study methods: Multiple secondary measures in five groups. | 11 trial; outcome in the same participant groupA Randomized, Double-Blind, Placebo-Controlled Trial Comparing the Effects of Commercially Available Ubiquinone, Ubiquinol, and Geranylgeraniol Dietary Supplements on Plasma CoQ10 Concentrations ↗ | 150 healthy adults aged 40 and over allocated to five groups | - A Randomized, Double-Blind, Placebo-Controlled Trial Comparing the Effects of Commercially Available Ubiquinone, Ubiquinol, and Geranylgeraniol Dietary Supplements on Plasma CoQ10 Concentrations ↗
|
|---|
| Fatigue in healthy adults | Pooling three studies in healthy adults showed no convincing reduction in subjective fatigue.Hedges g −0.351 (95% CI −0.756…+0.053) | 1/4 Very lowPrecision of the estimate: small samples, intervals and uncertain clinical relevance Consistency of results: high heterogeneity Applicability to the stated group: the specified form, outcome, clinical background and population limit extrapolation Possible publication bias: asymmetry or incomplete publication Study methods: limitations in the assessment of design, reporting or attrition | 33 studies of this outcome in the reviewEffectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗ | healthy adults, three studies in the subgroup | - Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗
|
|---|
| Time to exhaustion on a cycle ergometer | In physically active men, ubiquinol gave no convincing advantage in cycling exercise time over six weeks.No between-group difference was found after 6 weeks, interaction p=0.79; final analysis 26 and 25. | 2/4 LowPrecision of the estimate: Exact between-group CIs were not extracted. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: The study tested the specific form, participant group and outcome stated. Possible publication bias: There are no specific data for a separate downgrade. Study methods: Some data are missing; the manufacturer participated in the study. | 11 trial; outcome in the same participant groupEffect of six weeks ubiquinol supplementation on mitochondrial respiratory function and exercise capacity in healthy males ↗ | 54 healthy physically active men randomised | - Effect of six weeks ubiquinol supplementation on mitochondrial respiratory function and exercise capacity in healthy males ↗
|
|---|
| Oxygen consumption at the end of the cycling test | No convincing difference in oxygen consumption at the end of the cycling test was found in physically active men.No between-group difference was found, interaction p=0.25; final analysis 25 and 24. | 2/4 LowPrecision of the estimate: Exact between-group CIs were not extracted. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: The study tested the specific form, participant group and outcome stated. Possible publication bias: There are no specific data for a separate downgrade. Study methods: Some data are missing; the manufacturer participated in the study. | 11 trial; outcome in the same participant groupEffect of six weeks ubiquinol supplementation on mitochondrial respiratory function and exercise capacity in healthy males ↗ | 54 healthy physically active men randomised | - Effect of six weeks ubiquinol supplementation on mitochondrial respiratory function and exercise capacity in healthy males ↗
|
|---|
| Change in oxygen consumption during the cycling test | No convincing difference in the change in oxygen consumption during the cycling test was found.No between-group difference was found, p>0.05; final analysis 25 and 24. | 2/4 LowPrecision of the estimate: Exact between-group CIs were not extracted. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: The study tested the specific form, participant group and outcome stated. Possible publication bias: There are no specific data for a separate downgrade. Study methods: Some data are missing; the manufacturer participated in the study. | 11 trial; outcome in the same participant groupEffect of six weeks ubiquinol supplementation on mitochondrial respiratory function and exercise capacity in healthy males ↗ | 54 healthy physically active men randomised | - Effect of six weeks ubiquinol supplementation on mitochondrial respiratory function and exercise capacity in healthy males ↗
|
|---|
| Maximum oxygen consumption in athletes | A review of studies in trained adults found no convincing advantage in maximum oxygen consumption.SMD 0.03 (95% CI −0.32…0.39) | 1/4 Very lowPrecision of the estimate: small samples, intervals and uncertain clinical relevance Consistency of results: insufficient data for a separate downgrade. Applicability to the stated group: the specified form, outcome, clinical background and population limit extrapolation Possible publication bias: insufficient data for a separate downgrade. Study methods: limitations in the assessment of design, reporting or attrition | 77 studies of this outcome in the reviewThe effects of coenzyme Q10 supplementation on exercise-induced oxidative stress and related physiological outcomes in athletes: a systematic review and meta-analysis ↗ | trained healthy adults, 7 studies, 8 comparisons | - The effects of coenzyme Q10 supplementation on exercise-induced oxidative stress and related physiological outcomes in athletes: a systematic review and meta-analysis ↗
|
|---|
| Handgrip strength | Studies in middle-aged and older people found no convincing advantage in handgrip strength.MD +1.85 kg (95% CI −2.08…+5.79), I² 89.6% | 1/4 Very lowPrecision of the estimate: small samples, intervals and uncertain clinical relevance Consistency of results: high heterogeneity Applicability to the stated group: the specified form, outcome, clinical background and population limit extrapolation Possible publication bias: insufficient data for a separate downgrade. Study methods: limitations in the assessment of design, reporting or attrition | 44 studies of this outcome in the reviewEffects of Coenzyme Q10 Supplementation on Muscle Health and Physical Capacity in Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗ | 155 adults in four trials with a mean or median age of 40 or over, including patients. | - Effects of Coenzyme Q10 Supplementation on Muscle Health and Physical Capacity in Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗
|
|---|
| Muscle soreness the next day | In untrained young men after two exercise sessions, next-day soreness was lower with ubiquinol than with placebo.In both BMI groups, pain was lower after ubiquinol, each p<0.001 according to figure 9. | 1/4 Very lowPrecision of the estimate: No numerical magnitude or CI for the between-group effect. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: A narrow protocol of two exercise sessions in untrained men. Possible publication bias: There are no specific data for a separate downgrade. Study methods: Several subgroups, conditions and time points. | 11 trial; outcome in the same participant groupPost-workout supplementation with CoQ10 and sports drink on exercise performance and muscle recovery after exercise in normal and overweight males ↗ | 42 untrained men aged 18–30, 21 each in the normal and elevated BMI groups | - Post-workout supplementation with CoQ10 and sports drink on exercise performance and muscle recovery after exercise in normal and overweight males ↗
|
|---|
| Muscle soreness on the third day | In the same study, soreness on the third day was lower with ubiquinol than with placebo.In both BMI groups, pain was lower after ubiquinol, each p<0.001 according to figure 9. | 1/4 Very lowPrecision of the estimate: No numerical magnitude or CI for the between-group effect. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: A narrow protocol of two exercise sessions in untrained men. Possible publication bias: There are no specific data for a separate downgrade. Study methods: Several subgroups, conditions and time points. | 11 trial; outcome in the same participant groupPost-workout supplementation with CoQ10 and sports drink on exercise performance and muscle recovery after exercise in normal and overweight males ↗ | 42 untrained men aged 18–30, 21 each in the normal and elevated BMI groups | - Post-workout supplementation with CoQ10 and sports drink on exercise performance and muscle recovery after exercise in normal and overweight males ↗
|
|---|
| Self-rated sleep quality | In healthy working adults, ubiquinol showed no convincing advantage in self-rated sleep in the whole group over eight weeks.The overall analysis found no significant advantage; a subgroup signal in stress-sensitive participants does not establish an overall effect. | 2/4 LowPrecision of the estimate: No exact CI for the overall contrast. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: The study tested the specific form, participant group and outcome stated. Possible publication bias: There are no specific data for a separate downgrade. Study methods: 52 of 60 in the analysis, exploratory subgroup. | 11 trial; outcome in the same participant groupReduced Form of Coenzyme Q10 Relieves Daily Life Stress and Improves Sleep Quality in Healthy Subjects with High Stress Sensitivity ↗ | 60 healthy working adults aged 30–64; 52 in the efficacy analysis (24 versus 28) | - Reduced Form of Coenzyme Q10 Relieves Daily Life Stress and Improves Sleep Quality in Healthy Subjects with High Stress Sensitivity ↗
|
|---|
| Memory test result | In adults aged 60 and over, ubiquinol gave no convincing advantage in the overall memory test result over 90 days.difference −0.09 (95% CI −0.32…+0.13) | 2/4 LowPrecision of the estimate: The exact CIs allow a small difference in either direction. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: The study tested the specific form, participant group and outcome stated. Possible publication bias: There are no specific data for a separate downgrade. Study methods: Substantial attrition and unequal analyses between groups. | 11 trial; outcome in the same participant groupEffect of Ubiquinol on Cognitive Function, Blood Pressure, Arterial Stiffness, and Biomarkers of Oxidative Stress and Inflammation in the Elderly: A Randomized Trial ↗ | 111 adults aged 60 and over randomised; memory assessed in 54 with ubiquinol and 44 with placebo. | - Effect of Ubiquinol on Cognitive Function, Blood Pressure, Arterial Stiffness, and Biomarkers of Oxidative Stress and Inflammation in the Elderly: A Randomized Trial ↗
|
|---|
| Information-processing speed | Ubiquinol showed no convincing advantage in information-processing speed compared with placebo.−0.03 (95% CI −0.24…+0.18) | 2/4 LowPrecision of the estimate: The exact CIs allow a small difference in either direction. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: The study tested the specific form, participant group and outcome stated. Possible publication bias: There are no specific data for a separate downgrade. Study methods: Substantial attrition and unequal analyses between groups. | 11 trial; outcome in the same participant groupEffect of Ubiquinol on Cognitive Function, Blood Pressure, Arterial Stiffness, and Biomarkers of Oxidative Stress and Inflammation in the Elderly: A Randomized Trial ↗ | 111 adults aged 60 and over allocated to groups; information-processing speed assessed in 48 with ubiquinol and 41 with placebo | - Effect of Ubiquinol on Cognitive Function, Blood Pressure, Arterial Stiffness, and Biomarkers of Oxidative Stress and Inflammation in the Elderly: A Randomized Trial ↗
|
|---|
| Muscle and fat-free mass | Pooling the studies found no convincing advantage in muscle or fat-free mass.Hedges g +0.10 (95% CI −0.26…+0.47). | 1/4 Very lowPrecision of the estimate: 120 participants, CI includes both directions. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: Mixed populations and measures, including fat-free mass. Possible publication bias: There are no specific data for a separate downgrade. Study methods: Small studies. | 44 studies of this outcome in the reviewEffects of Coenzyme Q10 Supplementation on Muscle Health and Physical Capacity in Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗ | 120 adults in four trials with a mean or median age of 40 or over, including patients. | - Effects of Coenzyme Q10 Supplementation on Muscle Health and Physical Capacity in Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗
|
|---|
| Body mass index | A review of studies in adults found no convincing change in body mass index.−0.06 kg/m² (95% CI −0.54…+0.42) | 1/4 Very lowPrecision of the estimate: small samples, intervals and uncertain clinical relevance Consistency of results: insufficient data for a separate downgrade. Applicability to the stated group: the specified form, outcome, clinical background and population limit extrapolation Possible publication bias: insufficient data for a separate downgrade. Study methods: limitations in the assessment of design, reporting or attrition | 1717 studies of this outcome in the reviewEffects of Coenzyme Q10 Supplementation on Anthropometric Indices in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗ | Adults with different health conditions; 17 trials measuring body mass index. | - Effects of Coenzyme Q10 Supplementation on Anthropometric Indices in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials ↗
|
|---|
| Skin hydration | In women aged 45–60, Q10Vital showed no convincing advantage in measured skin hydration over 12 weeks.The abstract reported no significant difference. | 1/4 Very lowPrecision of the estimate: 11 per group; the exact between-group estimate was not extracted. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: A specific water-soluble product and instrument-measured outcome. Possible publication bias: There are no specific data for a separate downgrade. Study methods: One small experiment, several measurements. | 11 trial; outcome in the same participant groupThe effect of dietary intake of coenzyme Q10 on skin parameters and condition: Results of a randomised, placebo-controlled, double-blind study ↗ | 33 healthy women aged 45–60; three groups of 11 women | - The effect of dietary intake of coenzyme Q10 on skin parameters and condition: Results of a randomised, placebo-controlled, double-blind study ↗
|
|---|
| Dermal thickness | Q10Vital showed no convincing advantage in measured dermal thickness compared with placebo.The abstract reported no significant difference. | 1/4 Very lowPrecision of the estimate: 11 per group; the exact between-group estimate was not extracted. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: A specific water-soluble product and instrument-measured outcome. Possible publication bias: There are no specific data for a separate downgrade. Study methods: One small experiment, several measurements. | 11 trial; outcome in the same participant groupThe effect of dietary intake of coenzyme Q10 on skin parameters and condition: Results of a randomised, placebo-controlled, double-blind study ↗ | 33 healthy women aged 45–60; three groups of 11 women | - The effect of dietary intake of coenzyme Q10 on skin parameters and condition: Results of a randomised, placebo-controlled, double-blind study ↗
|
|---|
| Area of wrinkles around the eyes | In women aged 45–60, water-soluble Q10Vital reduced the measured area of wrinkles around the eyes over 12 weeks compared with placebo.p=0.04 for each dose versus placebo | 1/4 Very lowPrecision of the estimate: small samples, intervals and uncertain clinical relevance Consistency of results: insufficient data for a separate downgrade. Applicability to the stated group: the specified form, outcome, clinical background and population limit extrapolation Possible publication bias: insufficient data for a separate downgrade. Study methods: limitations in the assessment of design, reporting or attrition | 11 trial; outcome in the same participant groupThe effect of dietary intake of coenzyme Q10 on skin parameters and condition: Results of a randomised, placebo-controlled, double-blind study ↗ | 33 healthy women aged 45–60, three groups of 11 | - The effect of dietary intake of coenzyme Q10 on skin parameters and condition: Results of a randomised, placebo-controlled, double-blind study ↗
|
|---|
| Skin response to ultraviolet light | Q10Vital showed no advantage in the minimum ultraviolet dose that causes skin redness.between-group p=0.49 | 1/4 Very lowPrecision of the estimate: small samples, intervals and uncertain clinical relevance Consistency of results: insufficient data for a separate downgrade. Applicability to the stated group: the specified form, outcome, clinical background and population limit extrapolation Possible publication bias: insufficient data for a separate downgrade. Study methods: limitations in the assessment of design, reporting or attrition | 11 trial; outcome in the same participant groupThe effect of dietary intake of coenzyme Q10 on skin parameters and condition: Results of a randomised, placebo-controlled, double-blind study ↗ | 33 healthy women aged 45–60; three groups of 11 women | - The effect of dietary intake of coenzyme Q10 on skin parameters and condition: Results of a randomised, placebo-controlled, double-blind study ↗
|
|---|